Eugene Arsenault’s Post

Are you struggling to fill out the Pharma Roles quickly? Discover how VDart helped a large North American Pharma chain onboard skilled hires in record time. #VDart #pharmacasestudy #pharmarecruitment #talentmanagement

Are you struggling to fill out the Pharma Roles quickly? Discover how VDart helped a large North American Pharma chain onboard skilled hires in record time. #VDart #pharmacasestudy #pharmarecruitment #talentmanagement

𝐄𝐱𝐜𝐢𝐭𝐢𝐧𝐠 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭𝐬 𝐢𝐧 𝐭𝐡𝐞 𝐄𝐮𝐫𝐨𝐩𝐞𝐚𝐧 𝐂𝐃𝐌𝐎 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲! 🌟 As the landscape of Contract Development and Manufacturing Organizations (CDMOs) in Europe continues to evolve, it’s crucial to stay informed about the latest trends and opportunities in this dynamic sector. From specialized capabilities to new investments and acquisitions, the European CDMO industry is buzzing with activity. Join me at #CDMOLive later this year to delve into the cutting-edge insights and advancements shaping the future of CDMOs in Europe. Discover how countries like France, Italy, and Germany are leading the pack with their well-established pharmaceutical industries and specialized manufacturing technologies. With a focus on high-potency products, sterile forms, and innovative drug delivery systems, CDMOs are adapting to meet the demands of modern pharmaceutical development. Don’t miss out on the chance to explore the top players, emerging trends, and strategic investments driving growth in the European CDMO landscape. Reach out to learn more about how you can be part of this exciting journey! #CDMOIndustry #PharmaManufacturing #Innovation

When I read the news that Sanofi is going to focus on only 12 Potential Blockbuster Drugs to maximize its Profitability, gives maximum returns to Investors, optimum utilization of its manufacturing plant, gives maximum satisfaction to their Sales and Marketing personnel, gives best to the Medical Professionals to get the Best for their patients. This is a big talk in the Industry today. When I look back the bold decisions our Guru took in Croslands was phenomenal. We never had hundreds of products that most of Pharma companies have. If a product is not having a minimum sales of Rs. 1 crore with the good profit margin only were retained. We always discontinued products if it is not contributed to the desired profits unless otherwise it is a complementary product for another fast moving product. This helped us to stand unique in the industry and one of the high profitable companies with highly satisfied, happy, dedicated employees....Certainly Croslands was one of the Best... What we thought 30 years back is being talked today by MNC Company like Sanofi....we were a Visionary Corporate. I am 100% Sure had the company not sold to Ranbaxy we would by now one of the top and highly profitable Pharma Companies of the world. All destiny....Shri Krishna decides...we follow it...

"We won't take the risk of patients being left unserved." Those are the words shared by our VP, Global Contract Manufacturing Leader Thomas P Wilson when he spoke with Tim Wright at Contract Pharma to discuss all things Pfizer CentreOne. Together, they discussed what sets us apart from other CDMOs, including: 🔎 Our proven Pfizer quality systems in place 💵 Our transparent and flexible approach to pricing to ensure no unwanted surprises 🔗 Our approach to ensuring robust and reliable supply chain management Watch the video below to find out more. 👇 https://lnkd.in/dHJwqA4r #CDMO #PharmaSupplyChain #DrugManufacturing

Exciting News: Prange Pharma GmbH and Adragos Pharma are set to acquire Fresenius Kabi cutting-edge manufacturing site in Halden, Norway! This strategic move expands our global presence and adds significant capacity for sterile liquid manufacturing. Dive into the details by clicking on this link to the press release. #PharmaIndustry #GlobalExpansion #CDMO #WeAreAdragos #Adragos #M&A Halden Næringsutvikling

It’s great to be able to put a significant investment in a fully SAHPRA compliant dedicated fleet for Adcock Ingram. A first in our industry. Thanks Bidvest and Motus for the vehicle supply, and Adcock for trusting us with their compliant freight. Another example of a partnership in motion with RTT. #Adcockfleet; #RTTpartnership; #pharmacompliance

Natco Pharma: PAT growth of 128% & Revenue growth of 62% in 9M-24 at a PE of 13 Strong Q3-24: PAT up 241% & Revenue up 55% YoY PAT down 42% and Revenue down 25% QoQ

Just finished my training and assessment on Documentation Management in Zuellig Pharma Corp.

The #Scope 3 Work Group is only one of four ongoing Work Groups for GEMI. Other work groups include #Environmental #Sustainability #Leadershp (ESL), #Contaminated #Plastics (CP), and #TradeAssociation #Sustainability #Forum (TASF).